Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 18, 2006 - Issue 9
291
Views
76
CrossRef citations to date
0
Altmetric
Research Article

Perspectives on Pulmonary Inflammation and Lung Cancer Risk in Cigarette Smokers

, &
Pages 667-677 | Received 06 Feb 2006, Accepted 23 Mar 2006, Published online: 06 Oct 2008

REFERENCES

  • Abu-Shakra M., Guillemin F., Lee P. Cancer in systemic sclerosis. Arthritis Rheumatism 1993; 36(4)460–464, [CSA]
  • Akhmedkhanov A., Toniolo P., Zeleniuch-Jacquotte A., Koenig K. L., Shore R. E. Aspirin and lung cancer in women. Br. J. Cancer 2002; 87: 49–53, [CSA], [CROSSREF]
  • Amandus H., Costello J. Silicosis and lung cancer in U.S. metal miners. Arch. Environ. Health 1991; 46(2)82–89, [CSA]
  • American cancer Society. Tobacco & cancer [online]. American Cancer Society, Atlanta, GA 8 January, 2001, http://www.cancer.org/tobacco/index.html, accessed 22 January 2006
  • Anttila T. I., Lehtinen T., Leinonen M., Bloigu A., Koskela P., Lehtinen M., Saikku P. Serological evidence of an association between chlamydial infections and malignant lymphomas. Br. J. Haematol. 1998; 103(1)150–156, [CSA], [CROSSREF]
  • Aoki K. Excess incidence of lung cancer among pulmonary tuberculosis patients. Jpn. J. Clin. Oncol. 1993; 23: 205–220, [CSA]
  • Argyris T. S., Slaga T. J. Promotion of carcinomas by repeated abrasion in initiated skin of mice. Cancer Res. 1981; 41: 5193–5195, [CSA]
  • Auerbach O., Stout A. P., Hammond E. D. Changes in bronchial epithelium in relation to cigarette smoking and in relation to lung cancer. N. Engl. J. Med. 1961; 265: 253–267, [CSA]
  • Baker R. R. Smoke chemistry. Tobacco production, chemistry and technology, D. Layten Davis, M. T. Nielsen. Blackwell Science, Malden, MA 1999; 398–439
  • Bombick D. W., Ayers P. H., Doolittle D. J. Cytotoxicity assessment of whole smoke and vapor phase of mainstream and sidestream cigarette smoke from three Kentucky reference cigarettes. Toxicol. Methods 1997; 7: 177–190, [CSA], [CROSSREF]
  • Brown L. M., Gridley G., Olsen J. H., Mellemkjaer L., Linet M. S., Fraumeni J. F., Jr. Cancer risk and mortality patterns among silicotic men in Sweden and Denmark. J. Occup. Environ. Med. 1997; 39(7)634–638, [CSA]
  • Carp H., Miller F., Hoidal J. R., Janoff A. Potential mechanism of emphysema: Alpha-1-proteinase inhibitor recovered from lungs of cigarette smokers contains oxidized methionine and has decreased elastase inhibitory capacity. Proc. Nat. Acad. Sci. USA 1979; 79: 2041–2045, [CSA], [CROSSREF]
  • Castonguay A., Rioux N., Duperron C., Jalbert G. Inhibition of lung tumorigenesis by NSAIDS: A working hypothesis. Exp. Lung Res. 1998; 24: 605–615, [CSA]
  • Chang J. C., Lesser M., Yoo O. H., Orlowski M. Increased cathepsin B-like activity in alveolar macrophages and bronchoalveolar lavage fluid from smokers. Am. Rev. Respir. Dis. 1986; 134: 538–541, [CSA]
  • Chang J., Yoo O. H., Lesser M. Cathepsin D activity is increased in alveolar macrophages and bronchoalveolar lavage fluid of smokers. Am. Rev. Respir. Dis. 1989; 140: 958–960, [CSA]
  • Clark R. A. F. Wound repair: Overview and general considerations. The molecular and cellular biology of wound repair, 2nd ed., R. A. F. Clark. Plenum Press, New York 1996; 3–50
  • Coggins C. R. E. A review of chronic inhalation studies with mainstream cigarette smoke, in rats and mice. Toxicol. Pathol. 1998; 26: 307–314, [CSA]
  • Coggins C. R. E. A review of chronic inhalation studies with mainstream cigarette smoke, in hamsters, dogs and non-human primates. Toxicol. Pathol. 2001; 29: 550–557, [CSA], [CROSSREF]
  • Cohen S. M., Ellwein L. B. Cell proliferation in carcinogenesis. Science 1990; 249: 1007–1011, [CSA]
  • Cohen S. M., Ellwein L. B. Genetic errors, cell proliferation, and carcinogenesis. Cancer Res. 1991; 51: 6493–6505, [CSA]
  • Cohen S. M., Purtillo D. T., Ellwein L. B. Pivotal role of increased cell proliferation in human carcinogenesis. Mod. Pathol. 1991; 4: 371–382, [CSA]
  • Crawford J. M. The gastrointestinal tract. Robbins pathologic basis of disease, 6th ed., R. S. Cotran, V. Kumar, T. Collins. W. B. Saunders, Philadelphia 1999; 775–844
  • Curtin G. M., Higuchi M. A., Ayres P. H., Swauger J. E., Mosberg A. T. Lung tumorigenicity in A/J and rasH2 transgenic mice following mainstream tobacco smoke inhalation. Toxicol. Sci. 2004; 81(1)26–34, [CSA], [CROSSREF]
  • de la Horra C., Varela J. M., Fernández-Alonso J., Medrano F. J., Respaldiza N., Montes-Cono M. A., Calderón E. J. Association between human Pneumocystis infection and small-cell lung carcinoma. Eur. J. Clin. Invest. 2004; 34: 229–235, [CSA], [CROSSREF]
  • Doll R., Hill A. B. A study of the aetiology of carcinoma of the lung. Br. Med. J. 1952; II: 1271–1286, [CSA]
  • Dong D., Xu G., Sun Y., Hu P. Lung cancer among workers exposed to silica dust in Chinese refractory plants. Scand. J. Work Environ. Health 1995; 21(2)69–72, [CSA]
  • Ekbom A., Helmick C., Zack M., Adami H. O. Ulcerative colitis and colorectal cancer—A population-based study. N. Engl. J Med. 1990; 323(18)1228–1233, [CSA]
  • Enomoto N., Kaneda Y., Toyoda C., Takeishi M., Imai M., Kaizuka H., Wada J. Association of lung cancer and pulmonary fibrosis pathological study of autopsy cases. J. Tokyo Women's Med. Coll. 1985; 55(2)198–210, [CSA]
  • Feinstein A. R. Clinical epidemiology: The architecture of clinical research. W. B. Saunders, Philadelphia 1985
  • Flory C. M. The production of tumors by tobacco tars. Cancer Res. 1941; 1: 262–276, [CSA]
  • Froggatt P. Introductory remarks. Advances in pharmacological sciences, Effects of nicotine on biological systems, F. Adlkofer, K. Thurau. Birkhäuser Verlag, Boston 1991; 1–4
  • Fujita J., Nelson N. L., Daughton D. M., Dobry C. A., Spurzem J. R., Irino S., Rennard S. I. Evaluation of elastase and antielastase balance in patients with bronchitis and pulmonary emphysema. Am. Rev. Respir. Dis. 1990; 142: 57–62, [CSA]
  • Gairola C. G., Galicki N. I., Cardozo C., Lai Y. -L., Lesser M. Cigarette smoke stimulates cathepsin B activity in alveolar macrophages of rats. Lab. Clin. Med. 1989; 114: 419–425, [CSA]
  • Gnape H., Gnape J., Brandén E., Koyi H., Arnholm B. Is chronic Chlamydia pneumoniae infection associated with lung cancer?. Abstracts Gen. Meeting, Am. Soc. Microbiol. 98th Meeting. 1998; 203, paper C-434
  • Greten F. R., Eckmann L., Greten T. F., Park J. M., Li Z. W., Egan L. J., Kagnoff M. F., Karin M. IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 2004; 118(6)671–674, [CSA], [CROSSREF]
  • Harris J. M., Cullinan P., McDonald J. C. Does cryptogenic fibrosing alveolitis carry an increased risk of death from lung cancer?. J. Epidemiol. Commun. Health 1998; 52(9)602–603, [CSA]
  • Harris R. E., Beebe-Donk J., Schuller H. M. Chemoprevention of lung cancer by non-steroidal anti-inflammatory drugs among cigarette smokers. Oncol. Rep. 2002; 9(4)693–695, [CSA]
  • Haussmann H. J., Rustemeier K., Elves R. G. The use of risk analysis on selecting cigarette smoke compounds for reduction: Risk analysis in an interconnected world. Proceedings of the Meeting of the Society for Risk Analysis, Seattle, December, 1–5. Society for Risk Analysis, McLean, VAUSA 2001
  • Hirayama T. Lung cancer in Japan: Effects of nutrition and passive smoking. Lung cancer: Causes and prevention. Proceedings of the International Lung Cancer Update Conference, M. Mizell, P. Correa. Verlag Chemie International, Deerfield Beach, FL 1984; 175–195
  • Holland L. M. Crystalline silica and lung cancer, a review of recent experimental evidence. Regul. Toxicol. Pharmacol. 1990; 12: 224–237, [CSA]
  • Hubbard R. C., Ogushi F., Fells G. A., Cantin A. M., Jallat S., Couetney M., Crystal R. G. Oxidants spontaneously released by alveolar macrophages of cigarette smokers can inactivate the active site of alpha-1 antitrypsin, rendering it ineffective as an inhibitor of neutrophil elastase. J. Clin. Invest. 1987; 80: 1289–1295, [CSA]
  • Hubbard R., Venn A., Lewis S., Britton J. Lung cancer and cryptogenic fibrosing alveolitis. Am. J. Respir. Crit. Care Med. 2000; 161(1)5–8, [CSA]
  • Hunninghake G. W., Crystal R. G. Cigarette smoking and lung destruction: Accumulation of neutrophils in the lung of cigarette smokers. Am. Rev. Respir. Dis. 1983; 128: 833–838, [CSA]
  • Hunninghake G. W., Davidson J. M., Rennard S. I., Szapiel S., Gadek J. E., Crystal R. G. Elastin fragments attract macrophage precursors to diseased sites in pulmonary emphysema. Science 1981; 212: 925–927, [CSA]
  • IARC. Tobacco smoking. IARC Monogr. Eval. Carcinogen. Risks Hum. 1985; 38: 15, [CSA]
  • Institute of Medicine. Clearing the smoke, assessing the science base for tobacco harm reduction, K. Stratton, P. Shetty, R. Wallace, S. Bondurant. National Academy Press, Washington, DC 2001
  • Iwamasa T., Miyagi J., Tsuhako K., Kinjo T., Kamada Y., Hirayasu T., Genka K. Prognostic implication of human papillomavirus infection in squamous cell carcinoma of the lung. Pathol. Res. Pract. 2000; 196(4)209–218, [CSA]
  • Jalbert G., Castonguay A. Effects of NSAIDS on NNK-induced pulmonary and gastric tumorigenesis in A/J mice. Cancer Lett. 1992; 66: 21–28, [CSA], [CROSSREF]
  • Kew R. R., Ghebrehiwet B., Janoff A. The fifth component of complement (C5) is necessary for maximal pulmonary leukocytosis in mice chronically exposed to cigarette smoke. Clin. Immunol. Immunopathol. 1987; 43: 73–81, [CSA], [CROSSREF]
  • Keystone Symposia. Inflammation and cancer. Breckinridge, COUSA, February 27–March 3, 2005
  • Kinoshita A., Hirose K., Taniguchi T., Soda H., Rikitake T., Tsurukawa Y., Kanda T., Hara K. Lung cancer associated with idiopathic interstitial pneumonia. Jpn. J. Thorac. Dis. 1990; 28(6)852–858, [CSA]
  • Kitahara M. A case of lung cancer accompanying diffuse interstitial fibrosing pneumonia. Jpn. J. Chest Dis. 1984; 43(10)859–865, [CSA]
  • Kobzik L. The lung. Robbins pathologic basis of disease, 6th ed., R. S. Cotran, V. Kumar, T. Collins. W. B. Saunders, Philadelphia 1999; 697–755
  • Kocazeybek B. Chronic Chlamydophila pneumoniae infection in lung cancer, a risk factor: A case-control study. J. Med. Microbiol. 2003; 52: 721–726, [CSA], [CROSSREF]
  • Komatsu H., Nagai H., Satou K., Kurashima A., Shishido H., Machida K., Kawabe Y., Akagawa S., Ootsuka Y., Nagayama N., Sakamoto E., Sagara Y., Fukushima K., Mouri M., Katayama T. Association of active pulmonary tuberculosis and malignant diseases: Clinical study. Kekkaku 1995; 70(4)281–284, [CSA]
  • Kominami E., Tsukahara T., Hara K., Katunuma N. Biosynthesis and processing of lysosomal cysteine proteinases in rat macrophages. FEBS Lett. 1988; 231: 225–228, [CSA], [CROSSREF]
  • Langman M. J., Cheng K. K., Gilman E. A., Lancashire R. J. Effect of anti-inflammatory drugs on overall risk of common cancer: Case-control study in general practice research database. Br. Med. J. 2000; 320: 1642–1646, [CSA]
  • Lashner B. A., Kane S. V., Hanauer S. B. Colon cancer surveillance in chronic ulcerative colitis: Historical cohort study. Am. J. Gastrol. 1990; 85(9)1083–1087, [CSA]
  • Laurila A. L., Anttila T., Laara E., Bloigu A., Virtamo J., Albanes D., Leinonen M., Saikku P. Serological evidence of an association between Chlamydia pneumoniae infection and lung cancer. Int. J. Cancer (Pred. Oncol.) 1997; 74(1)31–34, [CSA], [CROSSREF]
  • Lee H. J., Im J. G., Ahn J. M., Yeon K. M. Lung cancer in patients with idiopathic pulmonary fibrosis CT findings. J. Comput. Assist. Tomogr. 1996; 20(6)979–982, [CSA], [CROSSREF]
  • Lee J. J., Liu D., Lee J. S., Kurie J. M., Khuri F. R., Ibarguen H., Morice R. C., Walsh G., Ro J. Y., Broxson A., Hong W. K., Hittelman W. N. Long-term impact of smoking on lung epithelial proliferation in current and former smokers. JNCI 2001; 93(14)1081–1088, [CSA], [CROSSREF]
  • Lesser M., Galicki N., Cardozo C., Gariola C. G. Cathepsin L activity in alveolar macrophages of rats: Response to cigarette smoke. Am. J. Respir. Cell. Mol. Biol. 1989; 1: 371–376, [CSA]
  • Lesser M., Padilla M. L., Cardozo D. Induction of emphysema in hamsters by intratracheal instillation of cathepsin B. Am. Rev. Respir. Dis. 1992; 145: 661–668, [CSA]
  • Leuchtenberger C., Leuchtenberger R. Differential response of Snell's and C57 black mice to chronic inhalation of cigarette smoke. Pulmonary carcinogenesis and vascular alterations in lung and heart. Oncology 1974; 29: 122–138, [CSA]
  • Li Q., Hu K., Pan X., Cao Z., Yang J., Hu S. Detection of human papillomavirus types 16, 18 DNA related sequences in bronchogenic carcinoma by polymerase chain reaction. Chin. Med. J. 1995; 108(8)610–614, [CSA]
  • Littman A. J., Thornquist M. D., White E., Jackson L. A., Goodman G. E., Vaughan T. L. Prior lung disease and risk of lung cancer in a large prospective study. Cancer Causes Control 2004; 15: 819–827, [CSA], [CROSSREF]
  • Long W., Tsuda T., Hiraoka K., Kido M. Four cases of lung cancer associated with idiopathic interstitial pneumonia. JUOEH (Sangxo Ika Daigaku Zasshi) 1990; 12(2)251–260, [CSA]
  • Lundback B., Lindberg A., Lindstrom M., Ronmark E., Jonsson A. C., Jonsson E., Larsson L. G., Andersson S., Sandstrom T., Larsson K. Not 15, but 50% of smokers develop COPD?—Report from the obstructive lung disease in Northern Sweden studies. Res. Med. 2003; 97: 115–122, [CSA], [CROSSREF]
  • Matsushita H., Tanaka S., Saiki Y., Hara M., Nakata K., Tanimura S., Banba J. Lung cancer associated with usual interstitial pneumonia. Pathol. Int. 1995; 45: 925–932, [CSA]
  • Meckley D. R., Hayes J. R., Van Kampen K. R., Mosberg A., Swauger J. E. A responsive, sensitive and reproducible dermal tumor promotion assay for the comparative evaluation of cigarette smoke condensate. Regul. Toxicol. Pharmacol. 2004; 39: 135–149, [CSA], [CROSSREF]
  • Mio T., Romberger D. J., Thompson A. B., Robbins R. A., Heires A., Rennard S. I. Cigarette smoke induces interleukin-8 release from human bronchial epithelial cells. Am. J. Respir. Crit. Care Med. 1997; 155: 1770–1776, [CSA]
  • Mossman B. T., Lounsbury K. M., Reddy S. P. Oxidants and signaling by mitogen-activated protein kinases (MAPK) in lung epithelium. Am. J. Respir. Cell Mol. Biol. 2006, (abstr.). Epub ahead of print[CSA]
  • Moyer D. The tobacco reference guide, International [online]. International Union Against Cancer (UICC), GenevaSwitzerland 2000, GLOBALink, 2000. http://new.globalink.org/tobacco/trg/Chapter27/Chap27_InternationalPage67.html, accessed 21 January 2006. Chapter 27
  • Nadel J. A. Obstructive diseases, general principles and diagnostic approach. Textbook of respiratory medicine, 3rd ed., J. F. Murray, J. A. Nadel. W. B. Saunders, Philadelphia 2002; vol. 2: 1173–1185
  • Nagai S., Kusume K., Takeuchi M., Nishimura K., Mio T., Kitaichi M., Izumi T. Evaluation of protease mediated lung injury in patients with tobacco induced pulmonary emphysema or idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 1992; 145(4/2)A794, [CSA]
  • Nambu Y., Iwata T., Oida K., Kohri Y., Taguchi Y., Tomii K., Mino M., Yunoki Y., Ichijima K., Kobashi Y. Etiological examination of idiopathic interstitial pneumonia and lung cancer in autopsy cases. Nihon Kyobu Shikkan Gakkai Zasshi 1991; 29(10)1275–1281, [CSA]
  • National Cancer Institute. Smoking and health program. Toward less hazardous cigarettes, Summary: Four skin painting bioassays using condensate from experimental cigarettes, G. B. Gori. DHEW Publication (NIH), U.S. Government Printing Office, Washington, DC September, 1980; 1–29, Report No. 5
  • Niewoehner D. E., Kleinerman J., Rice D. B. Pathologic changes in the peripheral airways of young cigarette smokers. N. Engl. J. Med. 1974; 291: 755–758, [CSA]
  • Norman A. Cigarette design and materials. Tobacco production, chemistry and technology, D. Layten Davis, M. T. Nielsen. Blackwell Science, Malden, MA 1999; 353–387
  • Nugent F. W., Haggitt R. C., Gilpin P. A. Cancer surveillance in ulcerative colitis. Gastroenterology 1991; 100(5/1)1241–1248, [CSA]
  • Nukiwa T., Sakuraba S., Aiba A., Dambara T., Kira S. Does chronic inflammatory milieu in the peripheral airspace act as promoter for high incidence carcinogenesis in patients with idiopathic interstitial pneumonia (IIP)?. Am. Rev. Respir. Dis. 1990; 141(4/2)A61, [CSA]
  • Ogura T., Kondo A., Sato A., Ando M., Tamura M. Incidence and clinical features of lung cancer in patients with idiopathic interstitial pneumonia. Nihon Kyobu Shikkan Gakkai Zasshi 1997; 35(3)294–299, [CSA]
  • Ohtsuka Y., Ukita H., Masaki Y., Doi I., Munakata M., Kawakami Y., Homma Y. A prospective study of lung cancer in cases of idiopathic interstitial pneumonia. Nihon Kyobu Shikkan Gakkai Zasshi 1991; 29(5)560–565, [CSA]
  • Okano A., Khaled R. Cases of lung cancer accompanying idiopathic interstitial pneumonia. Jpn. J. Chest Dis. 1985; 44(1)25–29, [CSA]
  • Ozasa K., Watanabe Y., Ito Y., Suzuki K., Tamakoshi A., Seki N., Nishino Y., Kondo T., Wakai K., Ando M., Ohno Y. Dietary habits and risk of lung cancer death in a large-scale cohort study (JACC Study) in Japan by sex and smoking habit. Jpn. J. Cancer Res. 2001; 92(12)1259–1269, [CSA]
  • Paganini-Hill A., Chao A., Ross R. K., Henderson B. E. Aspirin use and chronic diseases: A cohort study of the elderly. Br. Med. J. 1989; 299: 1247–1250, [CSA]
  • Park J., Jin S. L., Song K. S., Tae S. S., Lim C. M., Koh Y., Sang D. L., Woo S. K., Won D. K., Kim D. S. The clinical characteristics of lung cancer in patients with idiopathic pulmonary fibrosis. Tuberc. Respir. Dis. 1999; 46(5)674–684, [CSA]
  • Perricone R., DeCarolis C., DeSanctis G., Fontana L. Complement activation by cigarette smoke condensate and tobacco infusion. Arch. Environ. Health 1983; 38: 176–179, [CSA]
  • Peters-Golden M., Wise R. A., Hochberg M., Stevens M. B., Wigley F. M. Incidence of lung cancer in systemic sclerosis. J. Rheumatol. 1985; 12(6)1136–1139, [CSA]
  • Peto R., Gray R., Collins R., Wheatley K., Hennekens C., Jamrozik K., Warlow C., Hafner B., Thompson E., Norton S., Gilliland J., Doll R. Randomized trial of prophylactic daily aspirin in British male doctors. Br. Med. J. 1988; 296: 313–316, [CSA]
  • Piazuelo E., Cebrian C., Escartin A., Jimenez P., Soteras F., Ortega J., Lanas A. Superoxide dismutase prevents development of adenocarcinoma in a rat model of Barrett's esophagus. World J. Gastroenterol. 2005; 11(47)7436–7443, [CSA]
  • Qi H. W., Chen W. Q., Li H. Z. Expression of human papillomavirus DNA in primary lung cancer tissue. J. Fourth Mil. Med. Univ. 1999; 20(9)759–762, [CSA]
  • Radosavljević T., Radosavljević R. Lung cancer and pulmonary tuberculosis—Coexistence or coincidence. Eur. J. Cancer 1998; 34(2)S30, OP141[CSA]
  • Rennard S. I., Daughton D. M. Smoking reduction and biological markers of response. Monaldi Arch. Chest Dis. 1993; 48(5)580–582, [CSA]
  • Rioux N., Castonguay A. Prevention of NNK-induced lung tumorigenesis in A/J mice by acetylsalicyclic acid and NS-398. Cancer Res. 1998; 58: 5354–5360, [CSA]
  • Robbins R. A., Gossman G. L., Nelson K. J., Koyama S., Thompson A. B., Rennard S. I. Inactivation of chemotactic factor inactivator by cigarette smoke. A potential mechanism of modulating neutrophil recruitment to the lung. Am. Rev. Respir. Dis. 1990; 142: 763–768, [CSA]
  • Rodgman A., Smith C. J., Perfetti T. A. The composition of cigarette smoke: A retrospective, with emphasis on polycyclic components. Hum. Exp. Toxicol. 2001; 19(10)573–595, [CSA], [CROSSREF]
  • Rosenberg L. Non-steroidal anti-inflammatory drugs and cancer. Prev. Med. 1995; 24: 107–109, [CSA], [CROSSREF]
  • Rosenthal A. K., McLaughlin J. K., Gridley G., Nyren O. Incidence of cancer among patients with systemic sclerosis. Cancer 1995; 76(5)910–914, [CSA], [CROSSREF]
  • Roumm A. D., Medsger T. A., Jr. Cancer and systemic sclerosis an epidemiologic study. Arthritis Rheumatism 1985; 28(12)1336–1340, [CSA]
  • Schreinemachers D. M., Everson R. B. Aspirin use and lung, colon, and breast cancer incidence in a prospective study. Epidemiology 1994; 5: 138–146, [CSA]
  • Senior R. M., Griffin G. L., Meacham R. P. Chemotactic activity of elastin-derived peptides. J. Clin. Invest. 1980; 66: 859–862, [CSA]
  • Shanghai Cancer Institute. A case-control study of lung cancer and pulmonary tuberculosis. Chin. J. Tuberculosis Respir. Dis. 1988; 11(3)190, [CSA]
  • Shankar A., Wang J. J., Rochtchina E., Yu M. C., Kefford R., Mitchell P. Association between circulating white blood cell count and cancer mortality: A population-based cohort study. Arch. Intern. Med. 2006; 166(2)188–194, [CSA], [CROSSREF]
  • Shapiro S. D. Electrolytic metalloproteinases produced by human mononuclear phagocytes. Am. J. Respir. Crit. Care Med. 1994; 150: S160–S164, [CSA]
  • Shoji S., Ertl R. F., Koyama S., Robbins R., Leikauf G., Von Essen S., Rennard S. I. Cigarette smoke stimulates release of neutrophil chemotactic activity from cultured bovine bronchial epithelial cells. Clin. Sci. 1995; 88: 337–344, [CSA]
  • Simmons W. S. (2002) Lung cancer risk as a function of cigarette design: Filtration, blend and yield. Cigarette risk and the potential for risk reduction. symposium proceedings, New Orleans, LA, 2002, 53–59, CORESTA Congress
  • Slaga T. J. SENCAR mouse skin tumorigenesis model versus other strains and stocks of mice. Environ. Health Perspect. 1986; 68: 27–32, [CSA]
  • Slaga T. J. Inhibition of the induction of cancer by antioxidants. Adv. Exp. Med. Biol. 1995; 369: 167–174, [CSA]
  • Slaga T. J., DiGiovanni J. Inhibition of chemical carcinogenesis. Chemical carcinogens, C. E. Searle. ACS Monograph 182, American Chemical Society, Washington, D.C 1984; 1279–1321
  • Slaga T. J., Nesnow S. SENCAR mouse skin tumorigenesis. Handbook of carcinogen testing, H. A. Milman. Noyes, Park Ridge, N.J 1985; 230–250
  • Slaga T. J., Budunova I. V., Gimenez-Conti I. B., Aldaz C. M. The mouse skin carcinogenesis model. J. Invest. Derm. Symp. Proc. 1996; 1(2)151–156, [CSA]
  • Szabo I., Sepp R., Nakamoto K., Maeda M., Sakamoto H., Uda H. Human papilloma virus not found in squamous and large cell lung carcinomas by polymerase chain reaction. Cancer 1994; 73(11)2740–2744, [CSA], [CROSSREF]
  • Tashiro T., Kuroda Y., Shigeno H., Goto J., Nasu M. Clinicopathological study of 50 cases of lung cancer associated with silicosis. Acta Med. Nagasaki 1990; 35(1–4)5–9, [CSA]
  • Thun M. J., Namboodiri M. M., Calle E. E., Flanders W. D., Heath C. W., Jr. Aspirin use and risk of fatal cancer. Cancer Res. 1993; 53: 1322–1327, [CSA]
  • Trefny J. Risk of bronchial carcinoma in persons with tuberculous lesions. Z. Erkrank. Atmungsorg. 1977; 149(3)313–318, [CSA]
  • Trichopoulos D., Psaltopoulou T., Orfanos P., Trichopoulou A., Boffetta P. Plasma C-reactive protein and risk of cancer: A prospective study from Greece. Cancer Epidemiol. Biomarkers Prev. 2006; 15(2)381–384, [CSA], [CROSSREF]
  • Turner-Warwick M., Lebowitz M., Burrows B., Johnson A. Cryptogenic fibrosing alveolitis and lung cancer. Thorax 1980; 35(7)496–499, [CSA]
  • Wang Y., Zhang Z., Lubet R., You M. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf. Oncogene 2005; 24(18)3042–3049, [CSA], [CROSSREF]
  • Wang Z., Dong D., Liang X., Qu G., Wu J., Xu X. Cancer mortality among silicotics in China's metallurgical industry. Int. J. Epidemiol. 1996; 25(5)913–917, [CSA]
  • Weill H., McDonald J. C. Exposure to crystalline silica and risk of lung cancer the epidemiological evidence. Thorax 1996; 15(1)97–102, [CSA]
  • Witschi H. A/J mouse as a model for lung tumorigenesis caused by tobacco smoke: Strengths and weaknesses. Exp. Lung Res. 2005; 31(1)3–18, [CSA]
  • Witschi H., Espiritu I., Peake J. L., Wu K., Maronpot R. R., Pinkerton K. E. The carcinogenicity of environmental tobacco smoke. Carcinogenesis 1997; 18: 575–586, [CSA], [CROSSREF]
  • Witschi H., Espiritu I., Dance S. T., Miller M. S. A mouse lung tumor model of tobacco smoke carcinogenesis. Toxicol. Sci. 2002; 68: 322–330, [CSA], [CROSSREF]
  • Wynder E. L., Graham E. A. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. A study of 684 proved cases. J. Am. Med. Assoc. 1950; 143: 329–336, Note. This article was reprinted in 1985 and 1992[CSA]
  • Wynder E. L., Graham E. A. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. A study of 684 proved cases. J. AM. Med. Assoc. 1985; 143: 329–336, [CSA]
  • Wynder E. L., Graham E. A. Tobacco smoking as a possible etiologic factor in bronchiogenic carcinoma. A study of six hundred and eighty-four proved cases. J. NIH Res. 1992; 4(5)63–72, [CSA]
  • Wynder E. L., Graham E. A., Croninger A. B. Experimental production of carcinoma with tobacco tar. Cancer Res. 1953a; 13: 855–864, [CSA]
  • Wynder E. L., Graham E. A., Croninger A. B. Study on the experimental production of cancer with tobacco tar. Proc. Am. Assoc. Cancer Res. 1953b; 1: 62–63, [CSA]
  • Wynder E. L., Graham E. A., Croninger A. B. Experimental production of carcinoma with tobacco tar. II. Tests with different mouse strains. Cancer Res. 1955; 15: 445–448, [CSA]
  • Yousem S. A., Ohori N. P., Sonmez-Alpan E. Occurrence of human papillomavirus DNA in primary lung neoplasms. Cancer 1992; 69(3)693–697, [CSA], [CROSSREF]
  • Zheng W., Blot W. J., Liao M. L., Wang Z. X., Levin L. I., Zhao J. J., Fraumeni J. F., Jr., Gao Y. -T. Lung cancer and prior tuberculosis infection in Shanghai. Br. J. Cancer 1987; 56(4)501–504, [CSA]

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.